Eleonora Daini

Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence

M. Zoli, J. Duskey, B. Ruozi, 2019, Pharmaceutics.

Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease

A. Grabrucker, A. Vilella, Chiara A. De Benedictis, 2020, Alzheimer’s Disease: Drug Discovery.

S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis

M. Zoli, T. Boeckers, C. Gomes, 2021, Translational Psychiatry.

Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice

A. Ottani, D. Giuliani, M. Zoli, 2023, Frontiers in Immunology.

Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease

D. Giuliani, M. Vendruscolo, F. Santorelli, 2021, Pharmaceuticals.

A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice

M. Zoli, A. Vilella, Wenjie Liao, 2021, Neuroscience Letters.

PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study

M. Zoli, J. Duskey, B. Ruozi, 2020, Pharmaceutics.

PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice

F. Zimetti, I. Zanotti, B. Papotti, 2023, Brain, Behavior, and Immunity.